| CLIRLIVIE CORCEPT THERAPEUTICS INCORPORATED
2308397 01 Feb 2024 | on 01 Feb 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of endocrine diseases and disorders; Pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; Pharmaceutical preparations for the treatment of metabolic diseases and disorders | | | CLIRLIVIE & Design Corcept Therapeutics Incorporated
2364349 25 Nov 2024 | on 25 Nov 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders | | 
